News tagged with glucagon
Study suggests possible link between two Type 2 diabetes drugs and pancreatic cancer
Two newer drugs used to treat Type 2 diabetes could be linked to a significantly increased risk of developing pancreatitis and pancreatic cancer, and one could also be linked to an increased risk of thyroid cancer, according ...
Medications
Sep 16, 2011 |
5 / 5 (3) |
0
|
Study: Most-used diabetes drug works in different way than previously thought
A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University ...
Diabetes
Jan 06, 2013 |
5 / 5 (3) |
0
|
Diet soda linked to increase in glucagon-like peptide 1 levels
(HealthDay) -- Drinking a diet soda before a glucose load is associated with increased glucagon-like peptide 1 (GLP-1) secretion in individuals with type 1 diabetes and healthy controls, but not in those with ...
Diabetes
Mar 22, 2012 |
5 / 5 (2) |
0
Doubling down against diabetes: Turbo-charged gut hormones
A collaboration between scientists in Munich, Germany and Bloomington, USA may have overcome one of the major challenges drug makers have struggled with for years: Delivering powerful nuclear hormones to specific tissues, ...
Medical research
Nov 13, 2012 |
5 / 5 (2) |
0
|
New findings on glucagon synthesis
Researchers at Karolinska Institutet in Sweden have shown that the cells that produce glucagon are stimulated by the hormone itself. A previous study by the same group demonstrated that this principle also applies to insulin. ...
Medical research
Dec 03, 2012 |
5 / 5 (2) |
0
|
Risk of pancreatitis doubles for those taking new class of diabetes drugs
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Medications
Feb 25, 2013 |
5 / 5 (2) |
1
|
Study finds molecular switch that controls liver glucose production, may offer target for type II diabetes therapy
In their extraordinary quest to decode human metabolism, researchers at the Salk Institute for Biological Studies have discovered a pair of molecules that regulates the liver's production of glucose -- the ...
Medical research
Apr 08, 2012 |
3 / 5 (2) |
0
|
Researchers discover protein that may represent new target for treating type 1 diabetes
Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have discovered a new protein that may play a critical role in how the human body regulates blood sugar levels. Reporting ...
Medical research
Jan 04, 2012 |
5 / 5 (1) |
0
|
Importance of diabetes genetic variants unclear
(HealthDay) -- Genetic variants associated with type 2 diabetes that affect glucagon-like peptide 1 (GLP-1) are not associated with GLP-1 levels or GLP-1-induced insulin secretion in healthy individuals, according ...
Diabetes
Apr 04, 2012 |
5 / 5 (1) |
0
Absolute incretin effect reduced in type 2 diabetes
(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) the absolute incretin effect is reduced compared with healthy individuals, but its relative importance is increased, particularly in first-phase ...
Diabetes
Jun 25, 2012 |
5 / 5 (1) |
0
Joslin researchers gain new understanding of diabetes and kidney disease
Scientists at Joslin Diabetes Center have identified biological mechanisms by which glucagon-like peptide-1 (GLP-1), a gut hormone, protects against kidney disease, and also mechanisms that inhibit its actions in diabetes. ...
Diseases, Conditions, Syndromes
Jul 23, 2012 |
5 / 5 (1) |
0
Bile acid sequestrant reduces glucose concentration in T2DM
(HealthDay)—For patients with type 2 diabetes taking metformin monotherapy, the bile acid sequestrant colesevelam reduces fasting and postprandial glucose concentrations without any effects on insulin concentration, ...
Diabetes
Jan 30, 2013 |
5 / 5 (1) |
0
New inflammation hormone link may pave way to study new drugs for Type 2 diabetes
A new link between obesity and type 2 diabetes found in mice could open the door to exploring new potential drug treatments for diabetes, University of Michigan Health System research has found.
Diabetes
May 15, 2012 |
1 / 5 (1) |
0
|
Glucagon
Glucagon, a hormone secreted by the pancreas, raises blood glucose levels. Its effect is opposite that of insulin, which lowers blood glucose levels. The pancreas releases glucagon when blood sugar (glucose) levels fall too low. Glucagon causes the liver to convert stored glycogen into glucose, which is released into the bloodstream. High blood glucose levels stimulate the release of insulin. Insulin allows glucose to be taken up and used by insulin-dependent tissues. Thus, glucagon and insulin are part of a feedback system that keeps blood glucose levels at a stable level. Glucagon belongs to a family of several other related hormones.
For more information about Glucagon, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
